Additional file 1 of Decreased overall mortality rate with Chinese herbal medicine usage in patients with decompensated liver cirrhosis in Taiwan

Additional file 1 Figure S1. The cumulative incidence of overall mortality in patients with decompensated liver cirrhosis based on Chinese herbal medicine (CHM) usage (before matching). Figure S2. A flow diagram presenting the study participants enrollment (from the database of outpatient and inpatient). Figure S3. The cumulative incidence of overall mortality in patients with decompensated liver cirrhosis based on Chinese herbal medicine (CHM) usage (from the database of outpatient and inpatient). Table S1 Composition of the most commonly used herbal formulas and single herbs in patients with decompensated liver cirrhosis in Taiwan. Table S2 Hazard ratios (95% CI) for overall mortality of patients with decompensated liver cirrhosis (before matching). Table S3 Demographic characteristics of patients with decompensated liver cirrhosis according to CHM usage in Taiwan (from the database of outpatient and inpatient). Table S4 Hazard ratios (95% CI) for overall mortality of patients with decompensated liver cirrhosis (from the database of outpatient and inpatient). Table S5. Distribution of the cumulative period of CHM treatment of CHM users of patients with decompensated liver cirrhosis in this study in Taiwan (during study period after the index date). Table S6. Average survival time of patients with decompensated liver cirrhosis between CHM and CHM non-users. Table S7. Parameters for counting the cumulative incidence of overall mortality at Fig. 2 for CHM non-users. Table S8. Parameters for counting the cumulative incidence of overall mortality at Fig. 2 for CHM users.